Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

Bsteh Gabriel; Hegen Harald; Riedl Katharina; Altmann Patrick; Auer Michael; Berek Klaus; Di Pauli Franziska; Ehling Rainer; Kornek Barbara; Monschein Tobias; Rinner Walter; Schmied Christiane; Wurth Sebastian; Zebenholzer Karin; Zinganell Anne; Zrzavy Tobias; Zulehner Gudrun; Deisenhammer Florian; Rommer Paulus; Leutmezer Fritz; Berger Thomas

首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

【24h】

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

机译：量化干扰素和醋酸乙醇酸盐在多发性硬化症中的疾病重新激活的风险：Viaadisc评分

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and purpose There is a lack of evidence guiding discontinuation of disease-modifying therapy (DMT) in relapsing multiple sclerosis (RMS). Thus, the objective of this study was to generate and validate a risk score for disease reactivation after DMT discontinuation in RMS.

机译：None

著录项

来源
《European journal of neurology: the official journal of the European Federation of Neurological Societies》 |2021年第5期|共8页
作者
Bsteh Gabriel; Hegen Harald; Riedl Katharina; Altmann Patrick; Auer Michael; Berek Klaus; Di Pauli Franziska; Ehling Rainer; Kornek Barbara; Monschein Tobias; Rinner Walter; Schmied Christiane; Wurth Sebastian; Zebenholzer Karin; Zinganell Anne; Zrzavy Tobias; Zulehner Gudrun; Deisenhammer Florian; Rommer Paulus; Leutmezer Fritz; Berger Thomas;
展开▼
作者单位

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Clin Rehabil Munster Dept Neurol Munster Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Graz Dept Neurol Graz Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Innsbruck Dept Neurol Innsbruck Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

Med Univ Vienna Dept Neurol Waehringer Guertel 18-20 A-1090 Vienna Austria;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词
discontinuation; disease-modifying therapy; multiple sclerosis; reactivation; risk AUTHOR; Please check the list of abbreviations;

机译：停药;疾病改性治疗;多发性硬化;再激活;风险作者;请检查缩写列表;

相似文献

外文文献
中文文献
专利

1. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases [J] . Rong Na, Dingwei Ye, Jun Qi, 亚洲男性学杂志（英文版） . 2016,第004期
2. Cardiac arrhythmia with premature ventricular contractures induced by interferon beta in a patient with multiple sclerosis [J] . Igor Sobol, Marina Sobol, Konstantin E.Balashov 神经免疫与神经炎症（英文版） . 2015,第001期
3. Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population [J] . Qi-Bing Liu, Lei Wu, Gui-Xian Zhao, 中华医学杂志（英文版） . 2015,第013期
4. Cardiac arrhythmia with premature ventricular contractures induced by interferon beta in a patient with multiple sclerosis [J] . Igor Sobol, Marina Sobol, Konstantin E.Balashov 神经免疫与神经炎症(英文版) . 2015,第001期
5. Comparison of subcutaneous interferon beta-la with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease (REGARD) study): a multicentre, randomised, parallel, open-label trial [J] . Daniel D Mikol, Frederik Barkhof, Peter Chang, Lancet Neurology . 2008,第10期

机译：复发性多发性硬化症患者皮下干扰素β-la与醋酸格拉替雷的比较（复发性MS疾病中REbif与醋酸格拉替雷的比较（REGARD研究）：一项多中心，随机，平行，开放标签的研究
6. Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme [J] . Jacqueline Palace, Martin Duddy, Michael Lawton, Journal of Neurology, Neurosurgery and Psychiatry . 2019,第3期

机译：评估在多发性硬化症中干扰素 - β和Glatiramer乙酸酯的长期有效性：英国多发性硬化风险共享计划的最终10年结果
7. The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis. [J] . Martin Duddy, Jacqueline Palace Practical neurology . 2016,第1期

机译：英国关于多发性硬化症中β-干扰素和醋酸格拉替雷的风险分担计划。六年级分析的结果。
8. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus (HCV) infection treated with alpha-interferon [C] . S. GEHRING, E. LAUSCH, U. KULLMER, Falk Symposium . 2002

机译：α-干扰素治疗慢性丙型肝炎病毒（HCV）感染儿童自身抗体和自身免疫性甲状腺疾病风险的患病率
9. Ameliorating Alzheimer’s Disease Tau Pathology Through Immunomodulation: A Novel Role for Interleukin 4 and Glatiramer Acetate [D] . Dionisio-Santos, Dawling Alberto 2019

机译：通过免疫调节改善阿尔茨海默氏病的Tau病理学：白介素4和醋酸格拉替雷的新作用
10. Research paper: Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme [O] . Jacqueline Palace, Martin Duddy, Michael Lawton, -1

机译：研究论文：评估β-干扰素和醋酸格拉替雷在多发性硬化症中的长期有效性：英国多发性硬化症风险分担计划的最终十年结果
11. Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score [O] . Gabriel Bsteh, Harald Hegen, Katharina Riedl, 2021

机译：量化干扰素后疾病重新激活的风险和多发性硬化症中的醋酸乙醇酸酯停药：Viaadisc评分
12. Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis. Comparative Effectiveness Review Number 150. [R] . Butler, M., Forte, M. L., Schwehr, N., 2015

机译：停止长期疾病改善治疗多发性硬化症的决策困境。比较效力评论编号150。

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

摘要

著录项

相似文献

相关主题

期刊订阅